Follow the 东富龙 stock price and the full insider trade history of the company, a listed issuer based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 东富龙 has logged 2 public disclosures. Market capitalisation: €9.3bn. The latest transaction was disclosed on 29 December 2023 (Purchase). Among the most active insiders: 郑效东. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
东富龙 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XSHE. Se centra en el desarrollo y la fabricación de productos farmacéuticos innovadores.